Singapore markets closed

CollPlant Biotechnologies Ltd. (CLGN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.35-0.15 (-2.73%)
At close: 03:30PM EST
5.44 +0.09 (+1.68%)
After hours: 06:26PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 61.27M
Enterprise value 35.39M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)5.65
Price/book (mrq)1.89
Enterprise value/revenue 3.30
Enterprise value/EBITDA -5.89

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3-27.60%
S&P500 52-week change 314.90%
52-week high 313.97
52-week low 34.70
50-day moving average 35.51
200-day moving average 36.99

Share statistics

Avg vol (3-month) 312.63k
Avg vol (10-day) 313.22k
Shares outstanding 511.45M
Implied shares outstanding 611.45M
Float 88.29M
% held by insiders 110.16%
% held by institutions 112.23%
Shares short (14 Nov 2023) 417.79k
Short ratio (14 Nov 2023) 41.41
Short % of float (14 Nov 2023) 40.21%
Short % of shares outstanding (14 Nov 2023) 40.16%
Shares short (prior month 12 Oct 2023) 431.54k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 320 Nov 2016
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023

Profitability

Profit margin -62.80%
Operating margin (ttm)-10,702.33%

Management effectiveness

Return on assets (ttm)-11.39%
Return on equity (ttm)-19.74%

Income statement

Revenue (ttm)10.72M
Revenue per share (ttm)0.95
Quarterly revenue growth (yoy)-60.60%
Gross profit (ttm)N/A
EBITDA -6.01M
Net income avi to common (ttm)-6.73M
Diluted EPS (ttm)-0.59
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)28.98M
Total cash per share (mrq)2.53
Total debt (mrq)3.1M
Total debt/equity (mrq)9.56%
Current ratio (mrq)11.85
Book value per share (mrq)2.83

Cash flow statement

Operating cash flow (ttm)-3.76M
Levered free cash flow (ttm)-2.92M